<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Bevacizumab,Bevacizumab.png,Chemotherapeutic agents,Humanizedmonoclonals,Chemotherapeutic agents,Humanizedmonoclonals,2004,5-fluorouracil,ATC code L01,Actinomycin,Alemtuzumab" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Bevacizumab - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Bevacizumab</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Bevacizumab</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD">
<center><b><a href="../../../m/o/n/Monoclonal_antibody.html#Applications" title="Monoclonal antibody">Therapeutic monoclonal antibody</a></b></center>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../m/o/n/Monoclonal_antibody.html#Production" title="Monoclonal antibody">Source</a></td>
<td bgcolor="#EEEEEE"><a href="../../../h/u/m/Human.html" title="Human">Human</a></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../a/n/t/Antigen.html" title="Antigen">Target</a></td>
<td bgcolor="#EEEEEE"><a href="../../../v/a/s/Vascular_endothelial_growth_factor.html" title="Vascular endothelial growth factor">VEGF</a></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=216974-75-3&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=216974-75-3&amp;rn=1" rel="nofollow">216974-75-3</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_L01_b60c.html" title="ATC code L01">L01</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=L01XC07" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=L01XC07" rel="nofollow">XC07</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=BTD00087" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=BTD00087" rel="nofollow">BTD00087</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">149,000 g/mol</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">100% (IV only)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">20 days (range: 11–50 days)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Licence data</a></td>
<td bgcolor="#EEEEEE">
<p><span class="reflink plainlinksneverexpand"><a href="http://www.emea.europa.eu/humandocs/Humans/EPAR/Avastin/Avastin.htm" class="external text" title="http://www.emea.europa.eu/humandocs/Humans/EPAR/Avastin/Avastin.htm" rel="nofollow">EU</a></span>&#160;<span class="reflink plainlinksneverexpand"><a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Bevacizumab&amp;SearchType=BasicSearch" class="external text" title="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Bevacizumab&amp;SearchType=BasicSearch" rel="nofollow">US</a></span></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C<small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><span class="Unicode">℞</span> P<small>rescription only</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE"><a href="../../../i/n/t/Intravenous_therapy.html" title="Intravenous therapy">Intravenous</a></td>
</tr>
</table>
<p><b>Bevacizumab</b> (trade name <b>Avastin®</b>) drug used in treatment of <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a> that targets the <a href="../../../a/n/g/Angiogenesis.html" title="Angiogenesis">angiogenesis</a> pathway.</p>
<p>It is used in combination with standard <a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">chemotherapy</a> drugs in patients with metastatic <a href="../../../c/o/l/Colorectal_cancer.html" title="Colorectal cancer">colorectal cancer</a>, although studies are underway to determine its effectiveness for patients with non-metastatic colorectal cancer as well. The U.S. <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a> approved bevacizumab for use in colon cancer <a href="../../../2/0/0/2004.html" title="2004">2004</a>. The medicine was developed by <a href="../../../g/e/n/Genentech.html" title="Genentech">Genentech</a> and is marketed, in the United States by Genentech and elsewhere by <a href="../../../h/o/f/Hoffmann-La_Roche_1ceb.html" title="Hoffmann-La Roche">Roche</a> (Genentech's parent company), under the <a href="../../../b/r/a/Brand.html" title="Brand">brand</a> name <b>Avastin</b>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Background"><span class="tocnumber">1</span> <span class="toctext">Background</span></a></li>
<li class="toclevel-1"><a href="#Clinical_use"><span class="tocnumber">2</span> <span class="toctext">Clinical use</span></a>
<ul>
<li class="toclevel-2"><a href="#Non_oncologic_uses"><span class="tocnumber">2.1</span> <span class="toctext">Non oncologic uses</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Side_effects"><span class="tocnumber">3</span> <span class="toctext">Side effects</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Background" id="Background"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/v/Bevacizumab.html" title="Edit section: Background">edit</a>]</span> <span class="mw-headline">Background</span></h2>
<p>Bevacizumab is a humanized <a href="../../../m/o/n/Monoclonal_antibody.html" title="Monoclonal antibody">monoclonal antibody</a>, and was the first commercially available <a href="../../../a/n/g/Angiogenesis_inhibitor.html" title="Angiogenesis inhibitor">angiogenesis inhibitor</a>. It stops <a href="../../../t/u/m/Tumor.html" title="Tumor">tumor</a> growth by preventing the formation of new blood vessels by targeting and inhibiting the function of a natural protein called <a href="../../../v/a/s/Vascular_endothelial_growth_factor.html" title="Vascular endothelial growth factor">vascular endothelial growth factor</a> (VEGF) that stimulates new blood vessel formation.</p>
<p>The drug was first developed as a genetically engineered version of a mouse antibody that contains both human and mouse components. Genentech is able to produce the antibody in production-scale quantities.</p>
<p><a name="Clinical_use" id="Clinical_use"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/v/Bevacizumab.html" title="Edit section: Clinical use">edit</a>]</span> <span class="mw-headline">Clinical use</span></h2>
<p>Bevacizumab was approved by the <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) in February 2004 for use in <a href="../../../c/o/l/Colorectal_cancer.html" title="Colorectal cancer">colorectal cancer</a> when used with standard chemotherapy treatment. It was approved by the <a href="../../../e/m/e/EMEA_0f1c.html" title="EMEA">EMEA</a> in January 2005 for use in <a href="../../../c/o/l/Colorectal_cancer.html" title="Colorectal cancer">colorectal cancer</a>. <a href="../../../i/s/r/Israel.html" title="Israel">Israel</a> has also approved the use of bevacizumab.</p>
<p>Bevacizumab is usually given intravenously through the arm every 14 days. In colon cancer, it is given in combination with the chemotherapy drug 5-FU (<a href="../../../5/-/f/5-fluorouracil.html" title="5-fluorouracil">5-fluorouracil</a>), <a href="../../../l/e/u/Leucovorin.html" title="Leucovorin">leucovorin</a>, and <a href="../../../o/x/a/Oxaliplatin.html" title="Oxaliplatin">oxaliplatin</a> or <a href="../../../i/r/i/Irinotecan.html" title="Irinotecan">irinotecan</a>.</p>
<p>Bevacizumab has also demonstrated activity in <a href="../../../r/e/n/Renal_cell_cancer.html" title="Renal cell cancer">renal cell cancer</a> and <a href="../../../o/v/a/Ovarian_cancer.html" title="Ovarian cancer">ovarian cancer</a> when used as a single agent, and in <a href="../../../l/u/n/Lung_cancer.html" title="Lung cancer">lung cancer</a> and <a href="../../../b/r/e/Breast_cancer.html" title="Breast cancer">breast cancer</a> when combined with chemotherapy.</p>
<p>January 20, 2007: Researchers reported at the 2007 Gastrointestinal Cancers Symposium that a trial of bevacizumab (Avastin) as an addition to chemotherapy has shown no improvement in survival of patients with advanced pancreatic cancer. It may cause higher rates of high blood pressure, bleeding in the stomach and intestine, and intestinal perforations.</p>
<p><br /></p>
<p><a name="Non_oncologic_uses" id="Non_oncologic_uses"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/v/Bevacizumab.html" title="Edit section: Non oncologic uses">edit</a>]</span> <span class="mw-headline">Non oncologic uses</span></h3>
<p>Bevacizumab has recently been used by ophthalmologists as an intravitreal agent in the treatment of proliferative (neovascular) eye diseases, particularly for choroidal neovascular membrane (CNV) in age-related <a href="../../../m/a/c/Macular_degeneration.html" title="Macular degeneration">macular degeneration</a> (AMD). Although not currently approved by the FDA for such use, the injection of 1.25-2.5 mg of bevacizumab into the vitreous cavity has been performed without significant intraocular toxicity (although not studied in a contolled environment). Many retina specialists have noted impressive results in the setting of CNV, proliferative <a href="../../../d/i/a/Diabetic_retinopathy.html" title="Diabetic retinopathy">diabetic retinopathy</a>, <a href="../../../g/l/a/Glaucoma.html" title="Glaucoma">neovascular glaucoma</a>, diabetic <a href="../../../m/a/c/Macular_edema.html" title="Macular edema">macular edema</a>, and macular edema secondary to retinal vein occlusions.</p>
<p><a href="../../../r/a/n/Ranibizumab.html" title="Ranibizumab">Ranibizumab</a>, a Fab fragment derived from the same parent molecule as bevacizumab, has been developed by Genentech (by the same scientist Napoleone Ferrara) for intraocular use. This drug, under the trade name <b>Lucentis</b>, now has FDA approval. It has undergone extensive clinical trials. Reports indicate substantially better outcomes in patients treated with inravitreal Lucentis than conventional treatments in people with choroidal neovascularization (wet age related macular degeneration). Most patients with choroidal neovascularization lose vision or at best maintain vision despite treatment with laser, photodynamic therapy or Macugen. A much larger proportion (up to 70%) gained vision with Lucentis. Lucentis is however very expensive (<a href="../../../d/o/l/Dollar.html" title="Dollar">$</a>1500-2000 per injection, - the studies were done with monthly intravitreal injections). Bevacizumab is significantly cheaper (&lt;$100 a shot versus &gt;$1500) it appears to be safe (at least in the short term) and many doctors have noticed improvements in vision and outcomes similar to those seen with Lucentis. As Genentech has developed both drugs it has little interest in seeing Bevacizumab use in the eye and it is likely to remain off label. off-label use of this medication has created significant controversy in medical retina and vitreo-retinal surgery.</p>
<p>The <a href="../../../n/a/t/National_Eye_Institute_861d.html" title="National Eye Institute">National Eye Institute</a> (NEI)--of the <a href="../../../n/a/t/National_Institutes_of_Health_5b2b.html" title="National Institutes of Health">National Institutes of Health</a> (NIH)--announced in October 2006 that it would fund a comparative study trial of ranibizumab (Lucentis®) and bevacizumab (Avastin®) to assess the relative safety and effectiveness in treating AMD.</p>
<p><a name="Side_effects" id="Side_effects"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/v/Bevacizumab.html" title="Edit section: Side effects">edit</a>]</span> <span class="mw-headline">Side effects</span></h2>
<p>Several adverse side effects have been reported with bevacizumab. The main side effects of concern are <a href="../../../h/y/p/Hypertension.html" title="Hypertension">hypertension</a> and heightened risk of bleeding. Studies done particularly in lung cancer have shown that less than half of the patients with advanced disease qualify for treatment with this drug.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></p>
<p><a href="../../../b/o/w/Bowel_perforation.html" title="Bowel perforation">Bowel perforation</a> has also rarely been reported.</p>
<p>The FDA updated the label on the drug on September 25 2006, to note rare cases of brain capillary leak syndrome and nasal septum perforation.</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/v/Bevacizumab.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">Vamsidhar Velcheti, Avinash Viswanathan, Ramaswamy Govindan (June, 2006). "The Proportion of Patients with Metastatic Non-small Cell Lung Cancer Potentially Eligible for Treatment with Bevacizumab: A Single Institutional Survey". <i>Journal of Thoracic Oncology</i> <b>1</b> (5): 501.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+Proportion+of+Patients+with+Metastatic+Non-small+Cell+Lung+Cancer+Potentially+Eligible+for+Treatment+with+Bevacizumab%3A+A+Single+Institutional+Survey&amp;rft.title=Journal+of+Thoracic+Oncology&amp;rft.jtitle=Journal+of+Thoracic+Oncology&amp;rft.date=June%2C+2006&amp;rft.volume=1&amp;rft.issue=5&amp;rft.au=Vamsidhar+Velcheti%2C+Avinash+Viswanathan%2C++Ramaswamy+Govindan&amp;rft.pages=501">&#160;</span></li>
</ol>
<p><br /></p>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/v/Bevacizumab.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.avastin.com" class="external text" title="http://www.avastin.com" rel="nofollow">Avastin.com</a></li>
<li><a href="http://www.avastin-info.com" class="external text" title="http://www.avastin-info.com" rel="nofollow">Avastin-info.com Information for healthcare professionals outside of the US</a></li>
<li><a href="http://www.chemocare.com/bio/bio.sps?iBiographyID=10903" class="external text" title="http://www.chemocare.com/bio/bio.sps?iBiographyID=10903" rel="nofollow">Avastin Information from Chemocare.com</a></li>
<li><a href="http://www.nytimes.com/2006/02/15/business/15drug.html?ex=1297659600&amp;en=62aabaec5acffa8c&amp;ei=5090&amp;partner=rssuserland&amp;emc=rss" class="external text" title="http://www.nytimes.com/2006/02/15/business/15drug.html?ex=1297659600&amp;en=62aabaec5acffa8c&amp;ei=5090&amp;partner=rssuserland&amp;emc=rss" rel="nofollow">A Cancer Drug Shows Promise, at a Price That Many Can't Pay</a> <i><a href="../../../n/e/w/New_York_Times_d49e.html" title="New York Times">New York Times</a></i>, February 15, 2006, Alex Berenson</li>
<li><a href="http://www.cancer.gov/cancertopics/druginfo/bevacizumab" class="external text" title="http://www.cancer.gov/cancertopics/druginfo/bevacizumab" rel="nofollow">NCI Drug Information Summary on Bevacizumab for Patients</a></li>
<li><a href="http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=43234" class="external text" title="http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=43234" rel="nofollow">NCI Drug Dictionary Definition for Bevacizumab</a></li>
</ul>
<table class="navbox collapsible" style="margin: auto;">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; text-align:left; width:6em;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../c/h/e/Template%7EChemotherapeutic_agents_6333.html" title="Template:Chemotherapeutic agents"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../c/h/e/Template_talk%7EChemotherapeutic_agents_9814.html" title="Template talk:Chemotherapeutic agents"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../c/h/e/Template%7EChemotherapeutic_agents_6333.html" class="external text" title="http://en.wikipedia.org../../../c/h/e/Template%7EChemotherapeutic_agents_6333.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Chemotherapeutic agents/Antineoplastic agents</a> (<a href="../../../a/t/c/ATC_code_L01_b60c.html" title="ATC code L01">L01</a>)</th>
</tr>
<tr>
<th style=""><a href="../../../a/l/k/Alkylating_antineoplastic_agent.html" title="Alkylating antineoplastic agent">Alkylating agents</a></th>
<td style="" colspan="1"><i><a href="../../../n/i/t/Nitrogen_mustard.html" title="Nitrogen mustard">Nitrogen mustards</a>:</i> (<a href="../../../c/h/l/Chlorambucil.html" title="Chlorambucil">Chlorambucil</a>, <a href="../../../c/h/l/Chlormethine.html" title="Chlormethine">Chlormethine</a>, <a href="../../../c/y/c/Cyclophosphamide.html" title="Cyclophosphamide">Cyclophosphamide</a>, <a href="../../../i/f/o/Ifosfamide.html" title="Ifosfamide">Ifosfamide</a>, <a href="../../../m/e/l/Melphalan.html" title="Melphalan">Melphalan</a>). <i><a href="../../../n/i/t/Nitrosourea_compounds.html" title="Nitrosourea compounds">Nitrosoureas</a>:</i>(<a href="../../../c/a/r/Carmustine.html" title="Carmustine">Carmustine</a>, <a href="../../../f/o/t/Fotemustine.html" title="Fotemustine">Fotemustine</a>, <a href="../../../l/o/m/Lomustine.html" title="Lomustine">Lomustine</a>, <a href="../../../s/t/r/Streptozotocin.html" title="Streptozotocin">Streptozocin</a>). <i><a href="../../../p/l/a/Platinum.html" title="Platinum">Platinum</a>:</i> (<a href="../../../c/a/r/Carboplatin.html" title="Carboplatin">Carboplatin</a>, <a href="../../../c/i/s/Cisplatin.html" title="Cisplatin">Cisplatin</a>, <a href="../../../o/x/a/Oxaliplatin.html" title="Oxaliplatin">Oxaliplatin</a>, <a href="../../../b/b/r/BBR3464_ebcd.html" title="BBR3464">BBR3464</a>). <a href="../../../b/u/s/Busulfan.html" title="Busulfan">Busulfan</a>, <a href="../../../d/a/c/Dacarbazine.html" title="Dacarbazine">Dacarbazine</a>, <a href="../../../m/e/c/Mechlorethamine.html" title="Mechlorethamine">Mechlorethamine</a>, <a href="../../../p/r/o/Procarbazine.html" title="Procarbazine">Procarbazine</a>, <a href="../../../t/e/m/Temozolomide.html" title="Temozolomide">Temozolomide</a>, <a href="../../../t/h/i/ThioTEPA_d8ec.html" title="ThioTEPA">ThioTEPA</a>, <a href="../../../u/r/a/Uracil_mustard.html" title="Uracil mustard">Uramustine</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/n/t/Antimetabolite.html" title="Antimetabolite">Antimetabolites</a></th>
<td style="" colspan="1"><i><a href="../../../f/o/l/Folic_acid.html" title="Folic acid">Folic acid</a>:</i> (<a href="../../../a/m/i/Aminopterin.html" title="Aminopterin">Aminopterin</a>, <a href="../../../m/e/t/Methotrexate.html" title="Methotrexate">Methotrexate</a>, <a href="../../../p/e/m/Pemetrexed.html" title="Pemetrexed">Pemetrexed</a>, <a href="../../../r/a/l/Raltitrexed.html" title="Raltitrexed">Raltitrexed</a>). <i><a href="../../../p/u/r/Purine.html" title="Purine">Purine</a>:</i>(<a href="../../../c/l/a/Cladribine.html" title="Cladribine">Cladribine</a>, <a href="../../../c/l/o/Clofarabine.html" title="Clofarabine">Clofarabine</a>, <a href="../../../f/l/u/Fludarabine.html" title="Fludarabine">Fludarabine</a>, <a href="../../../m/e/r/Mercaptopurine.html" title="Mercaptopurine">Mercaptopurine</a>, <a href="../../../p/e/n/Pentostatin.html" title="Pentostatin">Pentostatin</a>, <a href="../../../t/i/o/Tioguanine.html" title="Tioguanine">Thioguanine</a>). <i><a href="../../../p/y/r/Pyrimidine.html" title="Pyrimidine">Pyrimidine</a>:</i>(<a href="../../../c/a/p/Capecitabine.html" title="Capecitabine">Capecitabine</a>, <a href="../../../c/y/t/Cytarabine.html" title="Cytarabine">Cytarabine</a>, <a href="../../../f/l/u/Fluorouracil.html" title="Fluorouracil">Fluorouracil</a>, <a href="../../../f/l/o/Floxuridine.html" title="Floxuridine">Floxuridine</a>, <a href="../../../g/e/m/Gemcitabine.html" title="Gemcitabine">Gemcitabine</a>)</td>
</tr>
<tr>
<th style=""><a href="../../../s/p/i/Spindle_poison.html" title="Spindle poison">Spindle poison plant alkaloids</a></th>
<td style="" colspan="1"><i><a href="../../../t/a/x/Taxane.html" title="Taxane">Taxane</a>:</i> (<a href="../../../d/o/c/Docetaxel.html" title="Docetaxel">Docetaxel</a>, <a href="../../../p/a/c/Paclitaxel.html" title="Paclitaxel">Paclitaxel</a>). <i><a href="../../../v/i/n/Vinca.html" title="Vinca">Vinca</a>:</i> (<a href="../../../v/i/n/Vinblastine.html" title="Vinblastine">Vinblastine</a>, <a href="../../../v/i/n/Vincristine.html" title="Vincristine">Vincristine</a>, <a href="../../../v/i/n/Vindesine.html" title="Vindesine">Vindesine</a>, <a href="../../../v/i/n/Vinorelbine.html" title="Vinorelbine">Vinorelbine</a>).</td>
</tr>
<tr>
<th style=""><a href="../../../a/n/t/Antineoplastic.html" title="Antineoplastic">Cytotoxic/antitumor antibiotics</a></th>
<td style="" colspan="1"><i><a href="../../../a/n/t/Anthracycline.html" title="Anthracycline">Anthracycline family</a>:</i> (<a href="../../../d/a/u/Daunorubicin.html" title="Daunorubicin">Daunorubicin</a>, <a href="../../../d/o/x/Doxorubicin.html" title="Doxorubicin">Doxorubicin</a>, <a href="../../../e/p/i/Epirubicin.html" title="Epirubicin">Epirubicin</a>, <a href="../../../i/d/a/Idarubicin.html" title="Idarubicin">Idarubicin</a>, <a href="../../../m/i/t/Mitoxantrone.html" title="Mitoxantrone">Mitoxantrone</a>, <a href="../../../v/a/l/Valrubicin.html" title="Valrubicin">Valrubicin</a>). <a href="../../../b/l/e/Bleomycin.html" title="Bleomycin">Bleomycin</a>, <a href="../../../h/y/d/Hydroxyurea.html" title="Hydroxyurea">Hydroxyurea</a>, <a href="../../../m/i/t/Mitomycin.html" title="Mitomycin">Mitomycin</a>, <a href="../../../a/c/t/Actinomycin.html" title="Actinomycin">Actinomycin</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/o/p/Topoisomerase_inhibitor.html" title="Topoisomerase inhibitor">Topoisomerase inhibitors</a></th>
<td style="" colspan="1"><i><a href="../../../c/a/m/Camptotheca.html" title="Camptotheca">Camptotheca</a>:</i> (<a href="../../../c/a/m/Camptothecin.html" title="Camptothecin">Camptothecin</a>, <a href="../../../t/o/p/Topotecan.html" title="Topotecan">Topotecan</a>, <a href="../../../i/r/i/Irinotecan.html" title="Irinotecan">Irinotecan</a>), <i><a href="../../../a/m/e/American_Mayapple_7e0c.html" title="American Mayapple">Podophyllum</a>:</i>(<a href="../../../e/t/o/Etoposide.html" title="Etoposide">Etoposide</a>, <a href="../../../t/e/n/Teniposide.html" title="Teniposide">Teniposide</a>).</td>
</tr>
<tr>
<th style=""><a href="../../../c/a/n/Cancer_immunotherapy.html" title="Cancer immunotherapy">CI</a> <a href="../../../m/o/n/Monoclonal_antibodies.html" title="Monoclonal antibodies">monoclonal antibodies</a></th>
<td style="" colspan="1"><a href="../../../a/l/e/Alemtuzumab.html" title="Alemtuzumab">Alemtuzumab</a>, <strong class="selflink">Bevacizumab</strong>, <a href="../../../c/e/t/Cetuximab.html" title="Cetuximab">Cetuximab</a>, <a href="../../../g/e/m/Gemtuzumab.html" title="Gemtuzumab">Gemtuzumab</a>, <a href="../../../p/a/n/Panitumumab.html" title="Panitumumab">Panitumumab</a>, <a href="../../../r/i/t/Rituximab.html" title="Rituximab">Rituximab</a>, <a href="../../../t/o/s/Tositumomab.html" title="Tositumomab">Tositumomab</a>, <a href="../../../t/r/a/Trastuzumab.html" title="Trastuzumab">Trastuzumab</a></td>
</tr>
<tr>
<th style=""><a href="../../../p/h/o/Photosensitizer.html" title="Photosensitizer">Photosensitizers</a></th>
<td style="" colspan="1"><a href="../../../a/m/i/Aminolevulinic_acid.html" title="Aminolevulinic acid">Aminolevulinic acid</a>, <a href="../../../m/e/t/Methyl_aminolevulinate.html" title="Methyl aminolevulinate">Methyl aminolevulinate</a>, <a href="../../../p/o/r/Porfimer_sodium.html" title="Porfimer sodium">Porfimer sodium</a>, <a href="../../../v/e/r/Verteporfin.html" title="Verteporfin">Verteporfin</a></td>
</tr>
<tr>
<th style=""><a href="../../../k/i/n/Kinase_inhibitor.html" title="Kinase inhibitor">Kinase inhibitors</a></th>
<td style="" colspan="1"><a href="../../../d/a/s/Dasatinib.html" title="Dasatinib">Dasatinib</a>, <a href="../../../e/r/l/Erlotinib.html" title="Erlotinib">Erlotinib</a>, <a href="../../../g/e/f/Gefitinib.html" title="Gefitinib">Gefitinib</a>, <a href="../../../i/m/a/Imatinib.html" title="Imatinib">Imatinib</a>, <a href="../../../l/a/p/Lapatinib.html" title="Lapatinib">Lapatinib</a>, <a href="../../../n/i/l/Nilotinib.html" title="Nilotinib">Nilotinib</a>, <a href="../../../s/o/r/Sorafenib.html" title="Sorafenib">Sorafenib</a>, <a href="../../../s/u/n/Sunitinib.html" title="Sunitinib">Sunitinib</a>, <a href="../../../v/a/n/Vandetanib.html" title="Vandetanib">Vandetanib</a> (ZD6474)</td>
</tr>
<tr>
<th style="">Other</th>
<td style="" colspan="1"><a href="../../../a/l/i/Alitretinoin.html" title="Alitretinoin">Alitretinoin</a>, <a href="../../../a/l/t/Altretamine.html" title="Altretamine">Altretamine</a>, <a href="../../../a/m/s/Amsacrine.html" title="Amsacrine">Amsacrine</a>, <a href="../../../a/n/a/Anagrelide.html" title="Anagrelide">Anagrelide</a>, <a href="../../../a/r/s/Arsenic_trioxide.html" title="Arsenic trioxide">Arsenic trioxide</a>, <a href="../../../a/s/p/Asparaginase.html" title="Asparaginase">Asparaginase</a>, <a href="../../../b/e/x/Bexarotene.html" title="Bexarotene">Bexarotene</a>, <a href="../../../b/o/r/Bortezomib.html" title="Bortezomib">Bortezomib</a>, <a href="../../../d/e/n/Denileukin_diftitox.html" title="Denileukin diftitox">Denileukin diftitox</a>, <a href="../../../e/s/t/Estramustine.html" title="Estramustine">Estramustine</a>, <a href="../../../h/y/d/Hydroxycarbamide.html" title="Hydroxycarbamide">Hydroxycarbamide</a>, <a href="../../../m/a/s/Masoprocol.html" title="Masoprocol">Masoprocol</a>, <a href="../../../m/i/t/Mitotane.html" title="Mitotane">Mitotane</a>, <a href="../../../p/e/g/Pegaspargase.html" title="Pegaspargase">Pegaspargase</a>, <a href="../../../t/r/e/Tretinoin.html" title="Tretinoin">Tretinoin</a></td>
</tr>
</table>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#ccccff;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../h/u/m/Template%7EHumanizedmonoclonals_ee5e.html" title="Template:Humanizedmonoclonals"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../h/u/m/Template_talk%7EHumanizedmonoclonals_45e2.html" title="Template talk:Humanizedmonoclonals"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../h/u/m/Template%7EHumanizedmonoclonals_ee5e.html" class="external text" title="http://en.wikipedia.org../../../h/u/m/Template%7EHumanizedmonoclonals_ee5e.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b>Humanized <a href="../../../m/o/n/Monoclonal_antibodies.html" title="Monoclonal antibodies">monoclonal antibodies</a></b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><a href="../../../a/l/e/Alemtuzumab.html" title="Alemtuzumab">Alemtuzumab</a>, <a href="../../../a/p/o/Apolizumab.html" title="Apolizumab">Apolizumab</a>, <a href="../../../a/s/e/Aselizumab.html" title="Aselizumab">Aselizumab</a>, <a href="../../../a/t/l/Atlizumab.html" title="Atlizumab">Atlizumab</a>, <a href="../../../b/a/p/Bapineuzumab.html" title="Bapineuzumab">Bapineuzumab</a>, <strong class="selflink">Bevacizumab</strong>, <a href="../../../b/i/v/Bivatuzumab_mertansine.html" title="Bivatuzumab mertansine">Bivatuzumab mertansine</a>, <a href="../../../c/a/n/Cantuzumab_mertansine.html" title="Cantuzumab mertansine">Cantuzumab mertansine</a>, <a href="../../../c/e/d/Cedelizumab.html" title="Cedelizumab">Cedelizumab</a>, <a href="../../../c/e/r/Certolizumab_pegol.html" title="Certolizumab pegol">Certolizumab pegol</a>, <a href="../../../c/i/d/Cidfusituzumab.html" title="Cidfusituzumab">Cidfusituzumab</a>, <a href="../../../c/i/d/Cidtuzumab.html" title="Cidtuzumab">Cidtuzumab</a>, <a href="../../../d/a/c/Daclizumab.html" title="Daclizumab">Daclizumab</a>, <a href="../../../e/c/u/Eculizumab.html" title="Eculizumab">Eculizumab</a>, <a href="../../../e/f/a/Efalizumab.html" title="Efalizumab">Efalizumab</a>, <a href="../../../e/p/r/Epratuzumab.html" title="Epratuzumab">Epratuzumab</a>, <a href="../../../e/r/l/Erlizumab.html" title="Erlizumab">Erlizumab</a>, <a href="../../../f/e/l/Felvizumab.html" title="Felvizumab">Felvizumab</a>, <a href="../../../f/o/n/Fontolizumab.html" title="Fontolizumab">Fontolizumab</a>, <a href="../../../g/e/m/Gemtuzumab_ozogamicin.html" title="Gemtuzumab ozogamicin">Gemtuzumab ozogamicin</a>, <a href="../../../i/n/o/Inotuzumab_ozogamicin.html" title="Inotuzumab ozogamicin">Inotuzumab ozogamicin</a>, <a href="../../../l/a/b/Labetuzumab.html" title="Labetuzumab">Labetuzumab</a>, <a href="../../../l/i/n/Lintuzumab.html" title="Lintuzumab">Lintuzumab</a>, <a href="../../../m/a/t/Matuzumab.html" title="Matuzumab">Matuzumab</a>, <a href="../../../m/e/p/Mepolizumab.html" title="Mepolizumab">Mepolizumab</a>, <a href="../../../m/o/t/Motavizumab.html" title="Motavizumab">Motavizumab</a>, <a href="../../../m/o/t/Motovizumab.html" title="Motovizumab">Motovizumab</a>, <a href="../../../n/a/t/Natalizumab.html" title="Natalizumab">Natalizumab</a>, <a href="../../../n/i/m/Nimotuzumab.html" title="Nimotuzumab">Nimotuzumab</a>, <a href="../../../n/o/l/Nolovizumab.html" title="Nolovizumab">Nolovizumab</a>, <a href="../../../n/u/m/Numavizumab.html" title="Numavizumab">Numavizumab</a>, <a href="../../../o/c/r/Ocrelizumab.html" title="Ocrelizumab">Ocrelizumab</a>, <a href="../../../o/m/a/Omalizumab.html" title="Omalizumab">Omalizumab</a>, <a href="../../../p/a/l/Palivizumab.html" title="Palivizumab">Palivizumab</a>, <a href="../../../p/a/s/Pascolizumab.html" title="Pascolizumab">Pascolizumab</a>, <a href="../../../p/e/c/Pecfusituzumab.html" title="Pecfusituzumab">Pecfusituzumab</a>, <a href="../../../p/e/c/Pectuzumab.html" title="Pectuzumab">Pectuzumab</a>, <a href="../../../p/e/r/Pertuzumab.html" title="Pertuzumab">Pertuzumab</a>, <a href="../../../p/e/x/Pexelizumab.html" title="Pexelizumab">Pexelizumab</a>, <a href="../../../r/a/l/Ralivizumab.html" title="Ralivizumab">Ralivizumab</a>, <a href="../../../r/a/n/Ranibizumab.html" title="Ranibizumab">Ranibizumab</a>, <a href="../../../r/e/s/Reslivizumab.html" title="Reslivizumab">Reslivizumab</a>, <a href="../../../r/e/s/Reslizumab.html" title="Reslizumab">Reslizumab</a>, <a href="../../../r/e/s/Resyvizumab.html" title="Resyvizumab">Resyvizumab</a>, <a href="../../../r/o/v/Rovelizumab.html" title="Rovelizumab">Rovelizumab</a>, <a href="../../../r/u/p/Ruplizumab.html" title="Ruplizumab">Ruplizumab</a>, <a href="../../../s/i/b/Sibrotuzumab.html" title="Sibrotuzumab">Sibrotuzumab</a>, <a href="../../../s/i/p/Siplizumab.html" title="Siplizumab">Siplizumab</a>, <a href="../../../s/o/n/Sontuzumab.html" title="Sontuzumab">Sontuzumab</a>, <a href="../../../t/a/c/Tacatuzumab_tetraxetan.html" title="Tacatuzumab tetraxetan">Tacatuzumab tetraxetan</a>, <a href="../../../t/a/d/Tadocizumab.html" title="Tadocizumab">Tadocizumab</a>, <a href="../../../t/a/l/Talizumab.html" title="Talizumab">Talizumab</a>, <a href="../../../t/e/f/Tefibazumab.html" title="Tefibazumab">Tefibazumab</a>, <a href="../../../t/o/c/Tocilizumab.html" title="Tocilizumab">Tocilizumab</a>, <a href="../../../t/o/r/Toralizumab.html" title="Toralizumab">Toralizumab</a>, <a href="../../../t/r/a/Trastuzumab.html" title="Trastuzumab">Trastuzumab</a>, <a href="../../../t/u/c/Tucotuzumab_celmoleukin.html" title="Tucotuzumab celmoleukin">Tucotuzumab celmoleukin</a>, <a href="../../../t/u/c/Tucusituzumab.html" title="Tucusituzumab">Tucusituzumab</a>, <a href="../../../u/m/a/Umavizumab.html" title="Umavizumab">Umavizumab</a>, <a href="../../../u/r/t/Urtoxazumab.html" title="Urtoxazumab">Urtoxazumab</a>, <a href="../../../v/i/s/Visilizumab.html" title="Visilizumab">Visilizumab</a></p>
</div>
</div>

<!-- 
Pre-expand include size: 48988 bytes
Post-expand include size: 27619 bytes
Template argument size: 12796 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/e/v/Bevacizumab.html">http://en.wikipedia.org../../../b/e/v/Bevacizumab.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../m/o/n/Category%7EMonoclonal_antibody_pages_needing_a_picture_58d4.html" title="Category:Monoclonal antibody pages needing a picture">Monoclonal antibody pages needing a picture</a></span> | <span dir='ltr'><a href="../../../d/r/u/Category%7EDrug_pages_needing_formula_fontification_abd9.html" title="Category:Drug pages needing formula fontification">Drug pages needing formula fontification</a></span> | <span dir='ltr'><a href="../../../a/n/g/Category%7EAngiogenesis_inhibitors_d112.html" title="Category:Angiogenesis inhibitors">Angiogenesis inhibitors</a></span> | <span dir='ltr'><a href="../../../c/a/n/Category%7ECancer_treatments_ae68.html" title="Category:Cancer treatments">Cancer treatments</a></span> | <span dir='ltr'><a href="../../../m/o/n/Category%7EMonoclonal_antibodies_272e.html" title="Category:Monoclonal antibodies">Monoclonal antibodies</a></span> | <span dir='ltr'><a href="../../../o/r/p/Category%7EOrphan_drugs_46b0.html" title="Category:Orphan drugs">Orphan drugs</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/e/v/Bevacizumab.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/e/v/Talk%7EBevacizumab_1ec9.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Bevacizumab">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/e/v/Bevacizumab.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../he/%D7%90/%D7%95/%D7%95/%D7%90%D7%95%D7%95%D7%A1%D7%98%D7%99%D7%9F.html">עברית</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E3%83%99/%E3%83%90/%E3%82%B7/%E3%83%99%E3%83%90%E3%82%B7%E3%83%84%E3%83%9E%E3%83%96.html">日本語</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 03:24, 30 March 2007 by Wikipedia user <a href="../../../p/e/n/User%7EPenmachine_b621.html" title="User:Penmachine">Penmachine</a>. Based on work by Wikipedia user(s) <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, Vamsidoc, <a href="../../../r/u/s/User%7ERussBot_6f95.html" title="User:RussBot">RussBot</a>, <a href="../../../f/v/a/User%7EFvasconcellos_4804.html" title="User:Fvasconcellos">Fvasconcellos</a>, <a href="../../../h/o/f/User%7EHoffmeier_a533.html" title="User:Hoffmeier">Hoffmeier</a>, <a href="../../../b/l/a/User%7EBlakeCS_39b1.html" title="User:BlakeCS">BlakeCS</a>, Cliv, Quietvillager, <a href="../../../s/t/e/User%7EStephP_6b99.html" title="User:StephP">StephP</a>, <a href="../../../c/o/l/User%7EColin_66ca.html" title="User:Colin">Colin</a>, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../r/o/b/User%7ERobert2957_6c90.html" title="User:Robert2957">Robert2957</a>, <a href="../../../s/k/e/User%7ESkerHawx_2728.html" title="User:SkerHawx">SkerHawx</a>, <a href="../../../s/e/v/User%7ESevero_afa8.html" title="User:Severo">Severo</a>, <a href="../../../h/a/w/User%7EHawkerTyphoon_6353.html" title="User:HawkerTyphoon">HawkerTyphoon</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../a/n/d/User%7EAndrew73_a1aa.html" title="User:Andrew73">Andrew73</a>, <a href="../../../e/p/o/User%7EEpolk_d8a6.html" title="User:Epolk">Epolk</a>, <a href="../../../g/j/e/User%7EGJeffery_6806.html" title="User:GJeffery">GJeffery</a>, <a href="../../../m/i/k/User%7EMikkalai_a7bb.html" title="User:Mikkalai">Mikkalai</a>, <a href="../../../t/w/e/User%7ETweeq_5aca.html" title="User:Tweeq">Tweeq</a>, Jordical, <a href="../../../l/e/i/User%7ELeif_7e14.html" title="User:Leif">Leif</a>, <a href="../../../r/y/z/User%7ERyz05_ef61.html" title="User:Ryz05">Ryz05</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, Carax, <a href="../../../s/a/m/User%7ESam_Hocevar_dccf.html" title="User:Sam Hocevar">Sam Hocevar</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a> and <a href="../../../s/h/a/User%7EShaile_c296.html" title="User:Shaile">Shaile</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
